{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T19:32:07Z","timestamp":1775071927120,"version":"3.50.1"},"reference-count":51,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American J Hematol"],"published-print":{"date-parts":[[2005,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Thrombophilia was implicated in the development of pregnancy complications, including recurrent idiopathic pregnancy loss, and is aggravated in women who are carriers of factor V G1691A (FV Leiden) and prothrombin (PRT) G20210A single\u2010nucleotide polymorphisms (SNPs). Previous studies examined the role of FV\u2010Leiden and PRT G20210A in recurrent pregnancy loss with conflicting results. Here we examined the prevalence of FV Leiden&amp;!rpar; and PRT G20210A SNPs, in 200 women with 3 or more consecutive early (<jats:italic>n<\/jats:italic> = 87), late (<jats:italic>n<\/jats:italic> = 41), or early\u2013late (<jats:italic>n<\/jats:italic> = 72) recurrent pregnancy losses, and 200 age\u2010matched fertile parous control women. APC resistance (APCR) was detected functionally (measuring the activated clotting time triggered by activated factor X in presence of a fixed amount of purified APC), and FV\u2010Leiden and PRT G20210A genotypes were assessed by PCR. The frequency of the mutant FV (0.1400 vs. 0.0276; <jats:italic>P<\/jats:italic> &lt; 0.001) but not PRT 20210 (0.0100 vs. 0.0225; <jats:italic>P<\/jats:italic> = 0.159) allele was higher in patients than controls, respectively. APC resistance with factor V Leiden was seen in 27% of patients compared to 11.5% of controls, while APC resistance without factor V Leiden was seen in 12.5% of patients compared to 9.5% of controls. Regression analysis demonstrated that the significant predictors for early abortion was FV Leiden; those for late abortion were oral contraceptive, APCR, and FV Leiden; and predictors for early\u2013late abortions were oral contraceptives, obesity, FV Leiden, and smoking. APC resistance and FV Leiden, as well as combination of both, are common thrombotic defects seen in women with idiopathic recurrent pregnancy loss, thus testing for these is recommended in women who have experienced recurrent miscarriages. Am. J. Hematol. 80:12\u201319, 2005. \u00a9 2005 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/ajh.20419","type":"journal-article","created":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T20:18:09Z","timestamp":1125605889000},"page":"12-19","source":"Crossref","is-referenced-by-count":25,"title":["Association between adverse pregnancy outcomes and maternal factor V G1691A (Leiden) and prothrombin G20210A genotypes in women with a history of recurrent idiopathic miscarriages"],"prefix":"10.1002","volume":"80","author":[{"given":"Touhami","family":"Mahjoub","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nabil","family":"Mtiraoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hala","family":"Tamim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sondes","family":"Hizem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramzi R.","family":"Finan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brahim","family":"Nsiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wassim Y.","family":"Almawi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,9]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-994957"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1080\/00365510310002905"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-2115(01)00496-1"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.10223"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccc.2004.05.002"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0001-6349.2004.00574.x"},{"key":"e_1_2_1_8_2","first-page":"911","article-title":"Venous thromboembolism. A review","volume":"48","author":"Thorneycroft IH","year":"2003","journal-title":"J Reprod Med"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2004.02.021"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200010053431405"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1086\/303082"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0029-7844(01)01789-6"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2000.02236.x"},{"key":"e_1_2_1_14_2","first-page":"217","article-title":"Resistance to activated protein C as risk factor for thrombosis; molecular mechanism, laboratory investigation and clinical management","volume":"34","author":"Dahlb\u00e4ck B.","year":"1997","journal-title":"Semin Haematol"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/369064a0"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.10.3698.bloodjournal88103698"},{"key":"e_1_2_1_17_2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/09674845.2004.11732662","article-title":"Factor V Leiden: association with venous thromboembolism in pregnancy and screening issues","volume":"61","author":"Harvey D","year":"2004","journal-title":"Br J Biomed Sci"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-0528.2003.02369.x"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1080\/713605679"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ede.0000112217.33111.23"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2003.06.007"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0378(97)00039-9"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(98)70465-X"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0029-7844(01)01190-5"},{"key":"e_1_2_1_25_2","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1055\/s-0037-1615119","article-title":"Multiplex ASA PCR for a simultaneous determination of factor V Leiden gene, GA 20210 prothrombin gene and CT 677 MTHFR gene mutations","volume":"79","author":"Hezard N","year":"1998","journal-title":"Thromb Haemost"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)04125-6"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1996.tb09887.x"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/12.7.1389"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.882901.x"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0412.2000.079011963.x"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1656110"},{"key":"e_1_2_1_32_2","first-page":"1633","article-title":"Prevalence of genetic markers for thrombophilia in recurrent pregnancy loss","volume":"6","author":"Howard C","year":"2002","journal-title":"Human Reprod"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0412.2003.00293.x"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(00)01545-4"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1995.tb05610.x"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1615035"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/12.5.1094"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.8755-8920.2000.430106.x"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(01)02971-5"},{"key":"e_1_2_1_40_2","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/17.6.1633"},{"key":"e_1_2_1_41_2","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1182\/blood.V91.4.1140","article-title":"Factor V Cambridge: a new mutation (Arg306\u2192Thr) associated with resistance to activated protein C","volume":"91","author":"Williamson D","year":"1998","journal-title":"Blood"},{"key":"e_1_2_1_42_2","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1182\/blood.V90.4.1552","article-title":"A factor V genetic component differing from factor V R506Q contributes to the activated protein C resistance phenotype","volume":"90","author":"Bernardi F","year":"1997","journal-title":"Blood"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1357-4310(97)01064-2"},{"key":"e_1_2_1_44_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.20.5.1382"},{"key":"e_1_2_1_45_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1995.tb05323.x"},{"key":"e_1_2_1_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2143(97)90097-4"},{"key":"e_1_2_1_47_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2004.00856.x"},{"key":"e_1_2_1_48_2","first-page":"688","article-title":"Prevalence of the FVQ506 (factor V Leiden) mutation in the normal and thrombophilic Algerian population","volume":"97","author":"Chafa O","year":"1997","journal-title":"Br J Haematol"},{"key":"e_1_2_1_49_2","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1055\/s-0037-1613361","article-title":"Absence of factor V Leiden mutation and low prothrombin G 20210 A mutation prevalence in a healthy Moroccan population","volume":"88","author":"Mathonnet F","year":"2002","journal-title":"Thromb Haemost"},{"key":"e_1_2_1_50_2","doi-asserted-by":"publisher","DOI":"10.1002\/1096-8652(200009)65:1<45::AID-AJH8>3.0.CO;2-V"},{"key":"e_1_2_1_51_2","first-page":"301","article-title":"Inherited resistance to activated protein C caused by presence of the FV: Q506 allele as a basis of venous thrombosis","volume":"26","author":"Dahlback B","year":"1996","journal-title":"Haemostasis"},{"key":"e_1_2_1_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0029-7844(97)00430-4"}],"container-title":["American Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fajh.20419","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajh.20419","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T07:48:17Z","timestamp":1700207297000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ajh.20419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["10.1002\/ajh.20419"],"URL":"https:\/\/doi.org\/10.1002\/ajh.20419","archive":["Portico"],"relation":{},"ISSN":["0361-8609","1096-8652"],"issn-type":[{"value":"0361-8609","type":"print"},{"value":"1096-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,9]]}}}